Mansel, R., Locker, G., Fallowfield, L., Benedict, Á., & Jones, D. (2007). Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial. Nature Publishing Group.
Chicago Style CitationMansel, R., G. Locker, L. Fallowfield, Á Benedict, i D. Jones. Cost-effectiveness Analysis of Anastrozole Vs Tamoxifen in Adjuvant Therapy for Early Stage Breast Cancer in the United Kingdom: The 5-year Completed Treatment Analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) Trial. Nature Publishing Group, 2007.
Cita MLAMansel, R., et al. Cost-effectiveness Analysis of Anastrozole Vs Tamoxifen in Adjuvant Therapy for Early Stage Breast Cancer in the United Kingdom: The 5-year Completed Treatment Analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) Trial. Nature Publishing Group, 2007.